טוען...
Defining the Ideal Time Interval between Planned Induction Therapy and Surgery for Stage IIIA Non-Small Cell Lung Cancer
BACKGROUND: Induction therapy leads to significant improvement in survival for selected patients with Stage IIIA non-small cell lung cancer (NSCLC). The ideal time interval between induction therapy and surgery remains unknown. METHODS: Clinical Stage IIIA NSCLC patients receiving induction therapy...
שמור ב:
| הוצא לאור ב: | Ann Thorac Surg |
|---|---|
| Main Authors: | , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5444908/ https://ncbi.nlm.nih.gov/pubmed/28110809 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.athoracsur.2016.09.053 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|